Please login to the form below

Not currently logged in
Email:
Password:

erectile dysfunction

This page shows the latest erectile dysfunction news and features for those working in and with pharma, biotech and healthcare.

FDA approves Sanofi's follow-on version of Lilly’s Humalog

FDA approves Sanofi's follow-on version of Lilly’s Humalog

Humalog is just one of Lilly’s big brands facing competition, along with erectile dysfunction therapy Cialis (tadalafil) and antiplatelet drug Effient (prasugrel), and the company recently announced sweeping job cuts

Latest news

More from news
Approximately 3 fully matching, plus 107 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Atlantis Healthcare

    prostate cancer. leukaemia. chronic obstructive pulmonary disease. diabetes. erectile dysfunction. glaucoma.

  • How technology is shaping patient education

    asthma[3] and erectile dysfunction.[4] Providing quality information and education will ultimately give patients greater control over their disease, increasing compliance and empowering the patient, all of which can lead

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The importance of co-creation with patients
Overcoming the barriers...
Three billboards on the road to multichannel
Chris Ross examines the trends driving multichannel communication in 2019...
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics